Hosted on MSN1mon
Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects growth to accelerate.Analyst firm Edward Jones expects Pfizer’s future growth to accelerate. Net income was $410 million, or 7 cents a share, after a loss of $3.37 billion, or 60 cents a share, in the prior year’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback